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Background/Objective: As studies have shown disparities in coronavirus disease-19 prevalence 
and severity, we sought to evaluate differences in outcomes of acute SARS-CoV-2 infection by 
race/ethnicity. 
Design: Systematic review 
Data Source: Studies from PubMed were included. 
Review methods: Articles published in English language from January 1, 2019 through March 
22, 2020. Studies included were observational studies that examined racial or ethnic disparities 
in SARS-CoV-2 infection outcomes in the United States. One reviewer performed data 
extraction. 
Results: Out of a possible 1,944 articles, 99 observational studies (82 individual-level and 17 
population-level) were included. Differential rates of hospitalization or otherwise severe illness 
(as indicated by intensive care unit admission, complications, and/or death) from coronavirus 
disease-19 (COVID-19) by race/ethnicity were reported, with many studies indicating higher 
rates of hospitalization for minority populations (particularly African American individuals) and 
results more mixed on differences in severe illness. Ecological studies showed associations 
between population-level proportion of minority residents and greater mortality from COVID-
19. There were few studies examining racial differences in pediatric populations. 
Conclusions: There are disparities in hospitalization for COVID-19, with non-Hispanic black and 
Hispanic individuals experiencing higher rates. This disparity is not consistently seen in case-
fatality among individuals receiving care, suggesting that social and economic inequity, rather 
than individual biological factors, drive individual-level COVID-19 hospitalization, as well as 
mortality at the population level. 
  
Introduction 
As of 25 March 2021, over 124 million confirmed cases of coronavirus disease 2019 
(COVID-19) and 2.7 million confirmed deaths have been reported in the world, with 30,014,615 
cases and 545,317 deaths in the United States (U.S.).1 COVID-19, caused by Severe Acute 
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was declared as a pandemic by the World 
Health Organization (WHO) on 11 March 2020.2 SARS-CoV-2 causes a range of illness, from 
asymptomatic infection to severe pneumonia and fatality. 
Various health professionals and organizations have noticed racial or ethnic disparities in 
rates of COVID-19 infection or COVID-19 outcomes, calling on health professionals, public 
health departments, and policy makers to recognize and mitigate the role of structural racism and 
other social and economic determinants on health in historically marginalized groups.3-6 While 
the impact of racial and ethnic minority status on poor health outcomes has long been 
recognized, COVID-19 has highlighted the disparity, with reports showing disproportionately 
high hospitalization and mortality rates for COVID-19 among minority populations.3, 7-9 
However, there has also been suggestion that, among patients receiving medical care, there is no 
disparity in clinical outcomes from COVID-19.10 
In order to assess racial and ethnic disparities in outcomes of COVID-19, we conducted a 
qualitative systematic review of studies in one database, with a focus on outcomes such as 
hospitalization, admission to the intensive care unit (ICU), death, or composite severity. Because 
of differences in COVID-19 mortality reported in county-level and individual-level analyses, we 




Studies were included if they were observational in nature (cohort, cross-sectional, case-
control, ecological) and examined children or adults in the United States. They had to include 
information on SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) or 
antibody testing in participants, and examine outcomes (mortality, hospitalization, admission to 
intensive care unit, severity, acute kidney injury, myocardial infarction, cerebrovascular 
incidents) of SARS-CoV-2 infection. Additionally, studies had to include data on SARS-CoV-2 
infection outcome by >1 race or ethnicity. Case reports and case series were not eligible for 
inclusion. Studies were excluded if they were not available in English language. 
Information Sources 
One online database (PubMed) was searched for relevant articles. The database was last 
searched on March 22, 2021. 
Search 
A literature search was conducted with the search terms: ‘covid-19,’ ‘coronavirus,’ 
‘SARS-CoV-2,’ or ‘severe acute respiratory syndrome’ in combination with ‘racial disparities,’ 
‘ethnic disparities,’ ‘hispanic,’ or ‘asian’ and ‘outcomes,’ ‘hospitalization,’ ‘hospital admission,’ 
‘intensive care,’ ‘mortality,’ or ‘severity.’ The search was filtered such that only results from 
2019 to March 22, 2021 were included. 
Study Selection 
After initial review, studies were screened by title and abstract by the author to determine 
potential relevance. The full-text articles determined to be relevant were then reviewed for 
inclusion in the systematic review, with duplicates being removed. 
Data Collection Process 
Data were taken directly from articles. No additional contact was made with authors of 
articles to obtain raw data or confirm results. If no comparison of COVID-19 outcomes was 




Results from study selection are shown in the study flow diagram in Figure 1. On the 
initial search, 1,944 studies were identified. Initial screening of title and abstract resulted in 
exclusion of 1,689 articles. Duplicates were removed to result in 243 possible studies. Full-text 
articles were then assessed for eligibility; after removal of ineligible articles as shown in Figure 
1, 99 studies remained. Characteristics of each study, including design, sample, location, 
outcomes, and results are given in Table 1. 
Study Characteristics 
Observational Studies 
 A total of 82 individual-level cohort and cross-sectional studies were eligible for 
inclusion, with 75 having a sample consisting of mostly adults (Table 1). These studies spanned 
from nationwide samples to regional and hospital samples, with representation from all states in 
the U.S. 
 Thirty-two studies examined differences in hospital admission by race/ethnicity. Of these, 
23 showed significantly higher ratios of hospitalization among black/non-Hispanic black 
individuals as compared to white/non-Hispanic white individuals,11-33 with four showing no 
difference.34-37 One study showed a nominally lower rate of hospitalization in Maya as compared 
to non-Maya patients.38 Twelve studies showed higher rates of COVID-19 hospitalization among 
Hispanic individuals as compared to non-Hispanic white individuals,13, 14, 17-21, 23, 25, 30, 31, 39 with 
six showing no difference12, 15, 24, 33, 35, 36 and two showing lower hospitalization among Hispanic 
individuals.16, 40 
 In contrast, most individual-level studies found statistically similar rates of COVID-19-
related mortality, severe illness and/or ICU admission between at least two race/ethnicities.10, 11, 
14-22, 24, 27, 29, 30, 32-37, 40-65 Twelve studies showed higher ratios of severe COVID-19 when 
comparing minority populations to non-Hispanic white populations.13, 15, 17, 25, 30, 31, 33, 39, 42, 50, 66-73 
Ten showed lower rates of severe COVID-19 among minority populations as compared to non-
Hispanic whites.10, 35, 53, 56, 71, 74-79 One study showed there was no significant difference in 
prevalence of COVID-19-related thrombotic events between race/ethnicities,80 and one study 
showed more severe radiographic presentation of lung disease among non-white vs. white 
patients with COVID-19.70 
Ecological Studies 
 A total of 17 population-level studies were eligible for inclusion (Table 1). Out of these 
studies, 15 showed a significant positive relationship between proportion of black or other 
minority residents in a geographic area (most often county-level) and COVID-19 mortality.81-95 
Five studies showed a significant positive relationship between proportion of Hispanic residents 
and COVID-19 mortality.83, 87, 90, 91, 93 Two showed no relationship between proportion of 
population considered a minority and COVID-19 mortality.96, 97 
Studies in Predominantly Pediatric Populations 
 Of the individual-level studies, seven had samples of all or mostly pediatric individuals. 
In the only study that included a sample of children with COVID-19 from across the U.S., non-
Hispanic black race/ethnicity predicted increased odds of hospitalization and death compared to 
non-Hispanic white race/ethnicity; Hispanic youth also had increased odds of hospitalization.98 
An increased risk of hospitalization and more severe illness was also seen among non-Hispanic 
black youth in two other studies,99, 100 and a high proportion of deaths due to COVID-19 in the 
U.S. was observed in Hispanic and non-Hispanic black children.101 However, a few studies have 
shown no differences in hospitalization, severe disease, or time to discharge in minority as 
compared to non-Hispanic white pediatric populations.45, 102, 103 
 
Discussion 
Summary of Evidence 
 Our systematic review revealed national studies and regional studies from across the U.S. 
that examined racial and ethnic differences in outcomes of COVID-19. While most individual-
level studies revealed disparities in hospitalization rates for COVID-19, those that studied in-
hospital mortality or case-fatality due to COVID-19 in individuals otherwise receiving care often 
showed no significant differences by race/ethnicity.10 This contrasts with population-level 
studies, where increases in black/other minority population was often associated with increase in 
COVID-19 related mortality.81 The combination of these two findings may suggest that 
disparities in hospitaliation and mortality are not necessarily due to individual-level differences 
in biology or health behaviors, but may be a result of limited access to care, limited health 
literacy, and the built environment. 
 Socioeconomic and health care inequities, in addition to structural racism, have long been 
known to contribute to adverse health outcomes (including chronic medical conditions), 
decreased health care access/utilization, and poor living circumstances.6 Consider, for example, 
the study by Hawkins et al., where black and Hispanic individuals were found to work more 
often in high-risk essential occupations and have higher age-adjusted mortality rates from 
COVID-19 than white individuals.104 This study suggests that black and Hispanic individuals 
may face a higher risk of exposure to SARS-CoV-2, as they are overrepresented in jobs that 
cannot be performed from home. Minority groups also have disproportionately high rates of low 
socioeconomic status;81 this may result in not only a need to work in occupations that require 
them to be in person but also more crowded living circumstances that promote spread of viral 
pathogens.105 Counties with higher levels of segregation were also shown to have higher rates of 
COVID-19-related mortality, which again suggests that racial inequity is a risk factor for poor 
outcomes related to COVID-19.94 Factors such as racial discrimination and other forms of racism 
may also result in diminished ability of communities and individuals to respond to public health 
emergencies and seek care, resulting in delay from presentation to treatment or no treatment at 
all.4, 106 Structural racism – and its ability to cause toxic levels of stress and resultant 
inflammation – may also increase risk for greater initial severity of COVID-19 illness.107 
Furthermore, diseases that have been associated with worse outcomes from SARS-CoV-
2, especially in the absence of proper treatment, tend to be more common among historically 
marginalized groups of people.6, 108 Many black, Hispanic, and other minority communities have 
poorer air quality, less access to healthy foods, less access to outdoor recreational areas, and 
higher rates of crime that lead to such diseases as obesity, hypertension, diabetes and chronic 
lung disorders that can worsen initial SARS-CoV-2 infection.109, 110 Thus, hospitalization rates 
may be higher among minority groups due to the burden of chronic disease they carry. 
Racial disparity in hospitalization also appears to exist among children, and there may be 
a higher odds of death from COVID-19 in non-Hispanic black children,98, 100 however, further 
studies must be conducted to more fully examine differences in outcomes in pediatric 
populations. Unfortunately, while children tend to suffer less severe disease, the future impact of 
disparities in COVID-19 outcomes among adults may result in increases in household 
dysfunction and adverse childhood experiences.111 Adverse childhood experiences often have 
intergenerational impacts, which may not bode well for future health in historically marginalized 
race/ethnicities. 
Limitations 
 In the current study, no quantitative synthesis was undertaken, which limits 
understanding of the results to a qualitative nature. Only one database was queried for articles, 
which may have limited the total number articles that could have been included in this review. 
Moreover, the author included several studies that were pre-printed and not yet peer reviewed. 
Ecological studies may suffer from ecological fallacy. We do not include studies from outside of 
the U.S. We recommend that observational studies examining differences in outcomes by 
race/ethnicity standardize by age, as not all did so in this review, and increasing age is known to 
be associated with significant increases in severity of illness. 
Conclusions 
 There is a need for more high-quality observational studies that examine differences in 
outcomes of COVID-19 disease, especially as the pandemic continues and evolves. Because 
hospitalization rates tend to be higher, but in-hospital or post-care mortality rates about the same, 
among minority race/ethnicities, our review suggests that social and economic inequity may 
drive disparities in outcome severity. However, access to care appears to aid in reducing 
mortality. Interventions that address the root cause of inequity (e.g., poverty, segregation, 
systemic racism) are needed to reduce disparities in COVID-19 outcomes. 
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Tables and Figures 
 
Figure 1. Study PRISMA flow 
diagram. 
Table 1. Characteristics for observational studies of COVID-19 outcome by race/ethnicity. 
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by county (est. 
(95% CI)) 
-- Asian: -0.27 (-0.41, -
0.12) 




White: 0.12 (-0.05, 
0.29) 








1,080 U.S.A. aOR (95% CI) for 
ICU admission 
NH white NH black: 1.6 (1.0, 
2.4) 
Hispanic: NS 
Other: NS  
Adegunsoye et al., 
202011 
Cohort SARS-CoV-2 + 
individuals 
785 Chicago, U.S.A. aOR (95% CI) for 
hospitalization, 
mortality 




1.01 (0.20, 5.0) 
Adhikari et al., 
202081 





-- 158 counties in 
U.S.A. 
Adjusted rate ratio 
(95% CI) for 
COVID-19 





white, less poverty: 
2.6 (1.1, 6.5) 
Substantially non-
white, more poverty: 
9.3 (4.7, 18.4) 
Akanbi et al., 
202097 
Ecological 70 zip codes in 
Oakland County 
1,257,584 Oakland County, 
Michigan, U.S.A. 
Incidence rate 
ratio (95% CI) for 
COVID-19 
mortality for each 
percentage point 
increase in black 
population at zip 
code level 
-- 1.00 (0.99, 1.01) 
Anaele et al., 
202182 




U.S.A. Increase in 
COVID-19 deaths 
-- 0.021 (0.009, 0.033) 
per 100,00 per 
percent increase 
in African 
American in state 
(est. (95% CI)) 
Antwi-Amoabeng 





172 Northern Nevada, 
U.S.A. 
aOR (95% CI) for 
COVID-19 
mortality 
Non-Hispanic Hispanic: 0.029 
(0.03, 3.14) 






340,059 U.S.A. Rate ratio (95% 
CI) for cumulative 
incidence of 
infection 
White persons American 
Indian/Alaska 
Native: 3.5 (1.2, 
10.1) 





aOR (P-value) for 
hospital 
admission 
NH white Black (0.007) 
Asian, Hispanic, 
other/unknown: NS 
Bailey et al., 
202199 
Cohort Individuals 
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aOR (95% CI) for 
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NH white Hispanic: 1.04 (0.84) 
Black: 1.21 (0.09) 
Asian: 2.36 (0.0017) 
Other: 1.22 (0.43) 
Bhargava et al., 
202043 
Cohort SARS-CoV-2 + 
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121 U.S.A. % of deaths by 
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NH A/PI: 4.1% 
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NH white: 14.0% 
Other: 1.7% 
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8.7 
AI/AN ages 18-49: 
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higher among NH 
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Veterans at 5 




NH white Hospitalization –  







ratio (95% CI) 
 
Adjusted relative 
risk for case 
fatality (95% CI) 
NH black: 4.2 (3.4, 
5.1) 
 
Case fatality –  
Hispanic: 0.9 (0.6, 
1.3) 
NH black: 0.9 (0.6, 
1.5) 
 
Cates et al., 202067 Cohort Adult veterans 
hospitalized with 
COVID-19 
4,305 U.S.A. Adjusted relative 
risk (95% CI) for 
several 
complications; we 
focus here on 
respiratory failure 
NH white NH black: 1.14 
(1.06, 1.23) 
NH other: 1.3 (1.08, 
1.58) 
Hispanic: 1.13 (0.99, 
1.28) 











rate ratio per 
100,000 (no 
significance tests) 









1,976 counties U.S.A. Daily incidence 











Top quantile % 
black: 1.70 (1.48, 
1.95) 
 
Top quantile % 
Hispanic: 1.50 (1.33, 
1.69) 





375 New York City, 
U.S.A. 
Comparison of 
crude case fatality 
rate due to 
COVID-19 
-- Black: 0.42 
Hispanic: 0.44 
Other: 0.33 






4,322 Atlanta, Georgia, 
U.S.A. 
Unadjusted OR 




NH white Hospitalization –  
NH black: 2.0 (1.6, 
2.5) 
Hispanic: 1.0 (0.7, 
1.4) 
NH Asian: 1.0 (0.6, 
1.9) 
 
ICU admission –  
NH black: 2.5 (1.6, 
3.7) 
Hispanic: 1.5 (0.8, 
2.7) 
NH Asian: 2.5 (1.0, 
6.1) 
 
Death –  
NH black: 1.4 (1.0, 
2.0) 
Hispanic: 0.6 (0.3, 
1.2) 
NH Asian: 0.5 (0.1, 
2.3) 
 





9,407 New York 
metropolitan 
region 
aOR (95% CI) for 
composite VTE or 
mortality 
White adults Asian: 1.08 (0.84, 
1.38) 
Black: 0.68 (0.57, 
0.81) 
Other: 0.81 (0.68, 
0.96) 














NH white Hospitalization –  
NH black: 1.39 
(1.16, 1.65) 
Hispanic: 0.77 (0.63, 
0.94) 
NH Asian: 1.53 
(1.14, 2.06) 
 
Death –  
NH black: 0.81 
(0.57, 1.14) 
Hispanic: 1.38 (0.80, 
2.36) 
NH Asian: 0.58 
(0.30, 1.11) 
 
Dai et al., 202117 Cohort SARS-CoV-2 + 




aOR (95% CI) for 
hospitalization 
White Hospitalization –  






Hispanic: 1.31 (1.22, 
1.42) 
Asian: 1.62 (1.43, 
1.84) 
NH/PI: 2.01 (1.55, 
2.61) 





Black: 1.05 (0.73, 
1.52) 
Hispanic: 1.41 (1.15, 
1.71) 
Asian: 0.93 (0.69, 
1.25) 
NH/PI: 1.17 (0.6, 
2.28) 
AI/AN: 1.92 (0.96, 
3.81) 
 
Dalsania et al., 
202184 
Ecological Counties in the 
U.S.A. 
2,026 counties U.S.A. Incidence rate 
ratio for COVID-
19 deaths for each 






-- 1.009 (1.005, 1.013) 






<21 admitted to 
PICU 
70 New York City, 
U.S.A. 
Adjusted hazard 
ratio (95% CI) for 
time to hospital 
discharge 
White patients Black/Latino: 2.76 
(0.93, 8.24) 
Other race: 1.00 
(0.29, 3.42) 













NH white adults Hospitalization –  
NH black: 1.47 
(1.03, 2.09) 
Hispanic: 1.42 (1.11, 
1.82) 
NH Asian: 1.47 
(1.13, 1.92) 
 
Death –  
NH black: 1.07 
(0.58, 1.98) 
Hispanic: 0.96 (0.57, 
1.63) 
NH Asian: 1.15 
(0.69, 1.92) 
 







4,299 Bronx, New 
York, U.S.A. 










White adults Asian: 1.97 (0.30, 
12.9) 
Black: 1.46 (.47, 
4.54) 
Hispanic: 1.67 (0.54, 
5.17 
Other: 2.09 (0.49, 
8.98) 
Fernandes et al., 
202145 








aOR (95% CI) for 
severe disease 
(≥48 hours in 
ICU) 
NH white youth NH black: 1.65 
(0.31, 8.87) 
Hispanic: 0.88 (0.26, 
2.98) 
Figueroa et al., 
202185 




U.S.A. Change in 
COVID-19 death 
rate per 100,000 
persons for each 




-- NH black: 9.3 (8.0, 
10.6) 
Hispanic: 0.4 (-1.5, 
2.4) 
NH other: -11.9 (-
14.0, -9.7) 













admitted to ICU, 
-- Hospitalization (non-
Maya vs. Maya): 
0.43 vs. 0.27 
(p=0.03) 
 
ICU admission: 0.14 





0.06 vs. 0.0 (p=0.01) 














ratio (95% CI) 
NH white NH black: 2.75 
(2.54, 2.97) 






observed in younger 
age groups 









ratio (95% CI) for 
severe COVID-19 
disease or death 
White  Non-white: 1.08 
(0.81, 1.44) 
Gershengorn et al., 
202119 
Cohort SARS-CoV-2 + 
adults 
1,256 Miami, Florida, 
U.S.A. 
aOR (95% CI) for 
hospitalization 
due to COVID-19 
and mortality due 
to COVID-19 
NH white Hospitalization –  
NH black: 3.47 
(2.44, 5.00) 
Hispanic black: 2.15 
(1.09, 3.99) 
Hispanic white: 2.43 
(1.78, 3.37) 
Other: 3.6 (2.37, 
5.44) 
 
Death –  
NH black: 0.92 
(0.11, 7.85) 
Hispanic black: 0.13 
(0.00, 7.13) 
Hispanic white: 1.35 
(0.29, 7.33) 









1,324 U.S.A. aOR (95% CI) for 
hospitalization 
and death due to 
COVID-19 
White Hospitalization –  
Black: 2.74 (1.9, 
3.95) 
Latinx: 1.71 (1.18, 
2.49) 





Death –  
Black: 1.39 (0.69, 
2.79) 
Latinx: 1.67 (0.81, 
3.41) 




Gil et al., 202147 Cohort Hospitalized 
SARS-CoV-2 + 
adults 
326 Rhode Island, 
U.S.A. 
Age-adjusted OR 
(95% CI) for 
death due to 
COVID-19 
NH white Hispanic: 1.0 (0.46, 
2.16) 





noted to be younger 
Girardin et al., 
202169 
Cohort SARS-CoV-2 + 
individuals 




4,446 New York City 












1.26 (1.10, 1.44) 
Golestaneh et al., 
202021 





2,934 Bronx, New 
York, U.S.A. 
aOR (95% CI) for 
hospitalization 
due to COVID-19 
 
Adjusted relative 





NH white Hospitalization –  
NH black: 1.7 (1.2, 
2.4) 
Hispanic: 1.5 (1.1, 
2.2) 
 
Mortality –  
NH black: 1.2 (0.7, 
2.0) 
Hispanic: 1.0 (0.6, 
1.7) 
 
Gottlieb et al., 
202034 
Cohort Patients at Rush 
University 
Medical Center 
8,673 Chicago, Illinois, 
U.S.A. 
aOR (95% CI) for 
hospitalization 
and critical illness 
due to COVID-19 
Black 
individuals 
Hospitalization –  
White: 1.04 (0.81, 
1.32) 
Asian: 0.99 (0.51, 
1.93) 
Other: 1.05 (0.78, 
1.40) 
 
Critical illness –  
White: 0.86 (0.61, 
1.19) 
Other: 1.21 (0.9, 
1.63) 






454 Colorado, U.S.A. OR (95% CI) for 
hospitalization 
due to COVID-19 
NH white Black: 1.12 (0.3, 4.3) 
Hispanic: 1.37 (0.7, 
2.7) 
Other: 0.98 (0.4, 2.4) 
Gu et al., 202022 Cohort Individuals 
positive for 
SARS-CoV-2 
when tested at 
University of 
Michigan 
1,139 Michigan, U.S.A. aOR (95% CI) for 
hospitalization 
and ICU 
admission due to 
COVID-19 
White Hospitalization –  
Black: 1.72 (1.15, 
2.58) 
Other: 1.42 (0.79, 
2.54) 
 
ICU Admission –  
Black: 1.15 (0.73, 
1.82) 
Other: 0.86 (0.42, 
1.78) 





529 New York City, 
New York, 
U.S.A. 





Other: 1.38 (0.75, 
2.56) 













mortality rate per 
100,000 persons 
(95% CI), by 
race/ethnicity 
-- NH white: 10.7 (9.5, 
12.0) 
Hispanic: 53.4 (43.4, 
63.4) 
NH black: 50.4 
(40.5, 60.2) 
NH Asian: 10.2 (5.5, 
14.9) 
Other: 34.1 (18.2, 
50.0) 
Hawkins et al., 
202086 
Ecological Counties 3,127 counties U.S.A. Adjusted rate ratio 




for each 1% 
increase in 
proportion of 
black people in 
county 
-- 1.03 (1.02, 1.05) 






438 29 states in 
U.S.A. 





White Black: 0.69 (0.40, 
1.20) 
Other: 0.68 (0.32, 
1.43) 
Ingraham et al., 
202023* 
Cohort SARS-CoV-2 + 
individuals 
5,577 12 Midwest 




hazard ratio (95% 
CI) for 
hospitalization 
due to COVID-19 
NH white Black: 1.31 (1.04, 
1.65) 
Asian: 1.78 (1.33, 
2.38) 
Hispanic: 3.02 (2.31, 
3.95) 
Other: 1.89 (1.18, 
3.03) 
Ioannou et al., 
202024 





10,131 U.S.A. Adjusted hazard 





White Hospitalization –  
Black: 1.13 (1.04, 
1.23) 





Death –  
Black: 1.04 (0.88, 
1.21) 





No differences by 
ethnicity 
Iyanda et al., 
202187 
Ecological Counties All U.S. 
counties 
U.S.A. Case fatality ratio 
(95% CI) for 




-- Black: 8.33 (4.9, 
14.2) 
Hispanic, non-white: 
5.93 (3.6, 9.7) 
AI: 2.70 (2.0, 3.6) 
A/PI: 1.66 (1.4, 1.9) 









NH white Hospitalization –  
NH black: 2.47 
(2.17, 2.81) 
Hispanic: 3.11 (2.37, 
4.18) 
AI/AN: 5.82 (3.25, 
10.43) 
Asian: 1.32 (0.93, 
1.87) 
 
Death –  
NH black: 2.81 
(2.62, 3.02) 
Hispanic: 3.31 (2.83, 
3.87) 
AI/AN: 4.22 (2.90, 
6.16) 
Asian: 1.50 (1.23, 
1.82) 








 Non-white vs. NH 
white: 
COVID-19 at a 
single institution 






6.1 vs. 4.2 
Adjusted average 
difference = 1.6 (0.5, 
2.7) 
Karmakar et al., 
202188 
Ecological Counties All counties in 
U.S.A. 
U.S.A. Incidence rate 
ratio (95% CI) for 
COVID-19-
related mortality 





-- Any racial/ethnic 












% Hispanic: 0.37 (-
0.12, 0.86) 
% Black: 0.66 (0.26, 
1.07) 






531 Atlanta, Georgia, 
U.S.A. 




White Black: 3.2 (1.8, 5.8) 







867 21 centers in the 
U.S.A. 












NH white NH black: 0.83 
(0.54, 1.28) 
Hispanic: 2.33 (1.47, 
3.70) 
NH Asian: 1.90 
(0.85, 4.27) 
Other: 3.40 (1.31, 
8.81) 




CoV-2 + adults 
5,416 12 states in 
U.S.A. 
Adjusted rate ratio 
(95% CI) for 
COVID-19-
NH white NH black: 4.0 (3.4-
4.8) 
Other: 3.3 (2.8-4.0) 
related 
hospitalization 
Krause et al., 
202051 




85 Colorado, U.S.A. aOR (95% CI) for 
COVID-19 30-
day mortality 









799 Michigan, U.S.A. aOR (95% CI) for 
COVID-19-
related death 
White Black: 0.61 (0.37, 
0.99) 
Other: 1.42 (0.58, 
3.49) 







193 New York City, 
New York, 
U.S.A. 






black: 2.69 (1.37, 
5.26) 
 
Death, black: 1.57 
(0.71, 3.46) 
Lazar et al., 202176 Cohort Adults with 




aOR (95% CI) for 
COVID-19 28-
day mortality 
White Persons of color: 
0.60 (0.37, 0.96) 
Li et al., 202090* Ecological Counties 2,990 counties U.S.A. Adjusted relative 
risk (95% CI) for 
COVID-19 
cumulative death 






-- NH black: 1.13 
(1.07, 1.19) 
Hispanic: 1.08 (1.02, 
1.14) 
AI/AN: 1.1 (1.05, 
1.15) 
Asian: 1.01 (0.97, 
1.06) 
NH/PI: 1.02 (0.98, 
1.05) 
Liao and Maio, 
202191 
Ecological Counties 3,141 counties U.S.A. Adjusted 
mortality rate 




by each one 
percent increase 
in specified 




race/ethnicity in a 
county 
Lucar et al., 202152 Cohort Adult patients 
with COVID-19 





OR (95% CI) for 
COVID-19-
related death 
All else besides 
non-Hispanic 
black 
NH black: 1.70 
(0.33, 8.81) 





patients at a 
single health 
system 
8,928 New York, 
U.S.A. 





White Hospitalization –  
African ancestry: 
1.47 (1.31, 1.64) 
Hispanic: 1.29 (1.14, 
1.46) 
Asian: 0.99 (0.89, 
1.20) 
 
Death –  
African ancestry: 
1.28 (1.10, 1.50) 
Hispanic: 1.09 (0.92, 
1.30) 
Asian: 0.84 (0.63, 
1.12) 
Luo et al., 202153 Cross-
sectional 
Veterans 




14,259 U.S.A. Case fatality rate 
ratio (95% CI) 
White Black: 0.75 (0.68, 
0.92) 
Asian: 0.55 (0.29, 
1.03) 
NH/PI: 0.62 (0.33, 
1.15) 
AI/AN: 1.05 (0.66, 
1.65) 





Ecological Counties 2,886 U.S.A. Correlation (r, p-
value) between 
COVID-19 case 











Marmarchi et al., 
202154 
Cohort COVID-19 adult 
patients admitted 
to the ICU in a 
single health 
care system 
288 Atlanta, Georgia, 
U.S.A. 
OR (95% CI) for 
COVID-19-
related death 
Non-black Black: 1.36 (0.75, 
2.47) 















White ICU admission –  
Black: 0.77 (0.39, 
1.53) 





Black: 0.39 (0.13, 
1.12) 
Latinx: 0.55 (0.23, 
1.29) 
Mikami et al., 
202056 
Cohort Patients with 
COVID-19 in a 
single health 
system 
6,493 New York, 
U.S.A. 
Adjusted hazard 




White Black: 0.78 (0.65, 
0.95) 
Asian: 0.94 (0.83, 
1.08) 
Other: 1.0 (0.83, 
1.19) 
Miller et al., 202077 Cohort SARS-CoV-2 + 
individuals 
presenting to an 








White Black: 0.56 (0.40, 
0.77) 













-- Non-black vs. black: 
0.013 vs. 0.187 













NH white Hospitalization –  
NH black: 2.28 
(1.93, 2.70) 
Hispanic: 1.38 (1.19, 
1.61) 
NH Asian: 1.11 
(0.78, 1.61) 
NH other: 2.95 
(2.28, 3.82) 
NH/PI: 0.25 (0.12, 
0.54) 
AI/AN: 0.20 (0.03, 
1.42) 
 
In-hospital death –  
NH black: 2.96 
(1.30, 6.73) 
Hispanic: 0.88 (0.36, 
2.13) 
NH other: 3.33 
(0.90, 12.37) 
Muhammad et al., 
202157 
Cohort Adult patients 
hospitalized for 




OR (95% CI) for 
COVID-19 
mortality 
Non-black Black: 1.52 (0.69, 
3.32) 


















Hospitalization –  
Black: 1.85 (1.0, 
3.67) 
 
ICU admission –  
Black: 1.52 (0.75, 
3.07) 
 
In-hospital death –  
Black: 1.43 (0.14, 
14.1) 










113 22 states in the 
U.S.A. 




NH white Minority 
race/ethnicity: 3.63 
(1.42, 9.70) 
Ogedegbe et al., 
202035 
Cohort Patients with 
COVID-19 in a 
health system 









NH white Hospitalization – 
NH black: 0.9 (0.7, 
1.1) 
Hispanic: 1.0 (0.8, 
1.2) 
Adjusted hazard 
ratio (95% CI) for 
COVID-19 
mortality 
NH Asian: 1.6 (1.1, 
2.3) 
NH other: 1.4 (1.0, 
1.9) 
  
Critical illness –  
NH black: 0.6 (0.4, 
0.8) 
Hispanic: 0.9 (0.7, 
1.2) 
NH Asian: 1.3 (0.9, 
1.8) 
NH other: 1.2 (0.8, 
1.8) 
 
Mortality –  
NH black: 0.7 (0.6, 
0.9) 
Hispanic: 1.0 (0.8, 
1.2) 
NH Asian: 1.3 (0.9, 
1.7) 
NH other: 0.9 (0.7, 
1.2) 
Ojinnaka et al., 
202093 
Ecological Counties 254 Texas, U.S.A. Regression (coef., 
95% CI) for 
prediction of 
COVID-19 
fatality per 100,00 
persons for 
percent increase 
in each specified 
race/ethnicity in a 
county 
-- NH black: 5.08 
(0.11, 10.04) 
NH white: 4.78 (-
0.28, 9.83) 
Asian: 5.17 (-0.11, 
10.45) 
Hispanic: 5.41 (0.52, 
10.31) 
Panagiotou et al., 
202178 
Cohort Nursing home 
residents with 
COVID-19 
5,256 U.S.A. aOR (95% CI) for 
30-day all-cause 
mortality 
White Black: 0.77 (0.62, 
0.96) 
Other: 0.60 (0.45, 
0.81) 




ratio (95% CI) (5-
unit change in 
independent 
variable) 
- For every 5% 
increase in black 
population –  
Rural: 1.051 (1.029, 
1.074)  
Urban: 1.041 (1.014, 
1.068) 







U.S.A. hospitals Adjusted risk ratio 
(95% CI) for ICU 
admission, 
mortality 
NH white ICU Admission –  
NH black: 1.02 
(1.00-1.03) 







Death –  
NH black: 0.96 (0.92 
– 0.99) 
NH Asian: 1.16 





Poulson et al., 
202072 









U.S.A. Adjusted risk ratio 
(95% CI) for ICU 
admission, 
mortality 




Mortality –  
Non-Hispanic black: 
1.36 (p<0.001) 





78,323 U.S.A. Adjusted risk ratio 




NH white Hospital Admission 
–  
Hispanic white: 1.35 
(1.32, 1.38) 
Hispanic black: 1.58 
(1.53, 1.64) 
Hispanic multiple / 
other: 1.50 (1.46, 
1.54)  
 
ICU Admission –  
Hispanic white: 1.30 
(1.18, 1.42) 
Hispanic black: 2.27 
(1.96, 2.63) 
Hispanic multiple / 
other: 2.06 (1.93, 
2.21)  
 
Mortality –  
Hispanic white: 1.36 
(1.31, 1.43) 
Hispanic black: 1.72 
(1.59, 1.86) 
Hispanic multiple / 




Cohort Patients with 
COVID-19 seen 
at an Ochsner 
health facility 




ratio (95% CI) for 
in-hospital death 
White Hospitalization –  
Black: 1.96 (1.62, 
2.37) 
 
In-hospital death –  
Black: 0.89 (0.68, 
1.17) 
Quan et al., 202158 Cohort Hospitalized 
adults with 
COVID-19 
2,038 Michigan, U.S.A. aOR (95% CI) for 
ICU admission 
and death 
White ICU admission –  
Black: 1.13 (0.88, 
1.44) 
 
Death –  
Black: 0.86 (0.64, 
1.14) 





4,790 U.S.A. aOR (95% CI) for 
ICU admission, 
death 
White ICU Admission –  
Black: 1.08 (0.95, 
1.23) 
Hispanic: 1.07 (0.86, 
1.33) 
 
Death –  
Black: 1.16 (0.97, 
1.38) 
Hispanic: 1.22 (0.90, 
1.66) 





734 Single hospital in 
New York, 
U.S.A. 
OR (95% CI) for 
hospitalization 
 
Hazard ratio (95% 
CI) for death 
White Hospitalization –  
Black: 1.89 (1.59, 
2.24) 
Hispanic: 0.84 (0.66, 
1.07) 
 
Death –  
Black: 1.30 (0.95, 
1.78) 
Hispanic: 1.84 (1.21, 
2.80) 
Asian: 2.06 (1.08, 
3.93) 
Other: 2.12 (1.11, 
4.06) 
Rentsch et al., 
202060 
Cohort Veterans tested 
for SARS-CoV-
2 
254,595 U.S.A. aOR (95% CI) for 
30-day COVID-
19 mortality 
White Black: 0.97 (0.80, 
1.17) 
Hispanic: 0.99 (0.73, 
1.34) 







7,868 88 hospitals in 
the U.S.A. 
aOR (95% CI) for 
in-hospital 
mortality 
NH white NH black: 0.93 
(0.76, 1.14) 
Hispanic: 0.90 (0.73, 
1.11) 
Asian: 1.31 (0.96, 
1.80) 
Rosenthal et al., 
202079 
Cohort Patients with 
COVID-19 






aOR (95% CI) for 
in-hospital 
mortality 




Saffary et al., 
202095 
Ecological Counties 3,108 U.S. 
Counties 
















NH white: -0.137 
 
Salter et al., 202136 Cross-
sectional 
Patients with MS 
and SARS-CoV-
2 in COViMS 
Registry 




NH white Hospitalization 
Black: 1.47 (0.98 – 
2.22) 
Hispanic/Latinx: 
0.77 (0.41 – 1.44) 
Other: 0.82 (0.33 – 
2.08)  
 



















patients in rural 
Southwest 
Georgia 




OR (95% CI) In-
Hospital Mortality 
White Black: 0.82 (0.37-
1.78) 




to an urban 
safety net 
hospital in New 
249 patients Safety Net 
Hospital in New 
Orleans, 
Louisiana, U.S.A. 

















years admitted to 
the ICU 






(95% CI) for in-
hospital mortality 




Other: 0.5 (0.1-2.7) 
Valenzuela et al., 
202040 
Cohort Hispanic and 
Non-Hispanic 
SARS-CoV-2+ 
patients at large 
suburban 
academic tertiary 
care hospital ER 
2,039 patients Long Island, New 
York, U.S.A. 














Mortality - Hispanic: 
0.82 (0.46-1.47) 








in March, 2020 
257 cases Stanford Health 
Care, U.S.A. 























Caucasian Black: 1.04 (0.815) 
Asian: 1.04 (0.914) 
Hispanic: 0.93 
(0.723) 
















aOR (95% CI) 






Mortality –  
Black: 1.24 (0.70-
2.25) 












49,701 cases Michigan, U.S.A. Age and sex-
standardized 
mortality rate 
ratios (95% CI) 
White Black: 6.9 (6.5,7.3) 
Latino: 2.2 (1.8, 2.6) 
A/PI: 2.2 (1.7, 2.7) 
Native American: 
0.7 (0.3, 1.3) 
Other: 4.2 (3.4, 5.1) 
 
*Denotes pre-print study; non-peer-reviewed 
NH = non-Hispanic 
AI/AN = American Indian or Alaska Native 
A/PI = Asian or Pacific Islander 
NH/PI = Native Hawaiian/Pacific Islander 
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